Published in Lab Law Weekly, January 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Affymetrix.
Report 1: Affymetrix Inc. (AFFX) announced that Wyeth (WYE) has signed another agreement with Affymetrix to use GeneChip microarray technology for 3 more years, further extending the relationship that began in 1994.
Under the agreement, Wyeth will continue to apply Affymetrix technology in numerous areas of the drug discovery and development process.
Report 2: Affymetrix, Inc., (AFFX) is collaborating with leading researchers around the world as part of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.